Equities – Page 22
-
White papers
Investing in 2022: Four key market drivers
The pandemic and rising inflation were prevailing drivers of markets in 2021. But the economic squeeze which dominated 2020 finally started to loosen its grip, as the world started to get back to something resembling ‘normality’ in the second half of last year.
-
White papers
CLOs: A Safe Haven Amid Rising Rates?
CLOs offer a number of potential benefits in a rising rate environment, with BB and equity tranches offering particular value.
-
White papers
What is driving the sudden spate of telecoms buyouts and is it good for investors?
The European telecommunication industry has been the problem child of the equity market for some years, writes Joe Howes, Credit Analyst
-
White papers
Hawkish Fed Makes Markets Rethink Pricing
Markets boosted and pulled forward rate hike expectations following the FOMC’s hawkish shift, with three hikes priced for 2022. While our baseline outlook sees the Fed tightening this year, we believe it will remain accommodative, so growth doesn’t slow too much and derail the recovery.
-
White papers
You asked, we answer - January 2022
A number of scheduled country-level elections will carry moderate uncertainty. However, while they could bring new faces, they are unlikely to result in abrupt changes from the current generally pro-European and market-friendly stance of large EU countries’ governments.
-
White papers
China’s growth cycle is turning
Senior market strategist APAC Chi Lo discusses how Beijing has shifted to a pro-growth policy and away from painful economic restructuring as growth momentum slows to levels below what is tolerable to Chinese policymakers.
-
White papers
Where are the opportunities in private equity?
It’s been a bumper period of performance - across the card - for private equity. Our experts explain why returns been so strong and offer their views on what comes next.
-
White papers
Factor investing: understanding your performance!
Multifactor strategies are based on investable portfolios, benchmarked against market capitalisation indices and tilted towards stocks with given characteristics (factors): they should be cheaper (value), more profitable (quality), less risky (low risk), and have outperformed in the past (momentum).
-
White papers
Omicron vs. the Fed
The volatility of the past two weeks may have had less to do with the virus and more to do with underlying cyclical uncertainties about growth, inflation and Fed policy.
-
White papers
Liquidity Stress Testing in Asset Management - Part 4. A Step-by-step Practical Guide
This article is part of a comprehensive research project on liquidity risk in asset management, which can be divided into three dimensions.
-
White papers
Q3 earnings season: results better than expected but doubts remain about next year
Q3 21 results were generally well above expectations, which was not taken for granted given the bottlenecks and higher input costs. However, the 2022 consensus remained very cautious, with EPS forecasts at best equivalent to nominal GDP growth! Good surprises cannot therefore be ruled out.
-
White papers
Real Rates Are the Key to This Cycle
Most of the consensus trades for 2021 failed in the second half of the year, and we think understanding why could be critical to unlocking the rest of this unique cycle.
-
White papers
Metaverse & the Disruption of the Internet
The sci-fi inspired vision behind an idealized metaverse is clear—but the road to get there is uncertain. As the industry tries to adapt existing business models to fit this new (virtual) reality, which companies will be the winners?
-
White papers
Shifts & Narratives #12 - ESG is not a given, the battle for data has just begun
ESG (environmental, social, and governance) investing has been making news headlines recently. With the rising adoption of ESG worldwide, regulatory scrutiny has started to intensify. The focus of this attention has been the assessment of what is effectively the integration of ESG principles into the traditional investment process versus what can sometimes appear to be the mere labelling of investment products as ESG with minimal effort to incorporate ESG aspects – a marketing push put in place to address fast growing investor demand.
-
White papers
Novo Nordisk Throws Its Weight Behind Patients With Obesity And Diabetes
The world’s obesity and sugar-high problems have healthcare budgets bursting at the seams.
-
White papers
Europe is poised to surprise
Over the past year, European equity markets have more than held their own relative to global equity markets. To the surprise of many, Europe has only marginally trailed the U.S. market while outperforming the broader MSCI World ex-U.S. Index. We believe Europe is poised for further positive surprise looking ahead.
-
White papers
What I learned on a trip through China
Amid heightened risk in China’s equity markets, portfolio manager Winnie Kwan shares first-hand experiences from her first post- COVID trip to China. She shines a light on:
-
White papers
From Mission Accomplished to Mission Impossible
Central banks will be rewarded for their crucial crisis response with more missions that threaten their effectiveness and independence.
-
White papers
Your Questions Answered: Sustainable Global Equity
Why Sustainable Global Equity and why now? What makes the fund unique? Is there a ‘green’ bubble? These are some of the questions our clients and prospective investors are asking about the some of Sustainable Global Equity fund.
-
White papers
A new dawn for Europe? Strategies for investing in European assets
The resurgence of Covid-19 cases in some countries is an area for attention, but should not lead to new generalised lockdowns due to vaccinations which are progressing at a strong pace.